New obesity pill and shot enter first human safety tests
NCT ID NCT06891287
First seen Apr 29, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This early-stage study tests the safety of a new drug called RT-114 in 60 healthy volunteers. Some will get a single dose as a pill or injection, others will get multiple doses or a placebo. The goal is to see if the drug is safe and how the body processes it, before testing it in people with obesity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network
RECRUITINGMelbourne, Victoria, Australia
Conditions
Explore the condition pages connected to this study.